Canhelp-Origin
Technology
Dedicated to research and development of innovative molecular diagnostic technology, Canhelp Genomics’ purpose is to improve cancer patient care by helping doctors to resolve diagnostic uncertainty, with evidence that is trustworthy and actionable.
Our technology focus on mRNA biomarkers of all cancer types and Artificial Intelligence for data analysis of the combination of genomics, clinical science and bioinformatics, in order to generate insights that can help on accurate diagnosis of cancers and enable physicians to match patients to more personalized treatments.
Publications
Over the years, our scientists have been committed to Research and Clinical Application of tumor biomarkers, and cooperating in depth with researchers and clinicians in various clinical fields all over the world. Since 2011, more than 80 research papers has published in international journals, such as Gastroenterology, Cell Research, Hepatology, Cancer Research, and Clinical Cancer Research.